Kedrion Biopharma is a biopharmaceutical company specializing in the collection and fractionation of blood plasma to produce products for the prevention and treatment of rare, severe diseases such as hemophilia, immune deficiencies, Rh sensitization, and passive vaccines. Headquartered in Italy, Kedrion has experienced steady growth and has expanded its global influence in the plasma industry, becoming one of the top five providers of plasma products worldwide. The company is committed to improving the quality of life for patients through its essential blood plasma products.